| [1] |
Wentao Zhu, Wanglong Hong, Miaomiao Zheng, Guoqiang Ma, Aizong Shen.
Combination of pembrolizumab and chemotherapy as first-line treatment in advanced triple-negative breast cancer: a cost-effectiveness analysis
[J]. Journal of Chinese Pharmaceutical Sciences, 2023, 32(7): 587-597.
|
| [2] |
Liangyu Liu, Yuke Yang, Xiao Du, Tong Wu, Jiannong Wang.
Three previously undescribed steroidal glycoalkaloids from Solanum lyratum and their anti-tumor activities
[J]. Journal of Chinese Pharmaceutical Sciences, 2022, 31(3): 192-201.
|
| [3] |
Huihui Song, Zhuo Xiang, Shuyi Xue, Qing Miao, Liyan Zhao, Mingchun Li.
Advances in anti-tumor effects and mechanisms of Pulsatilla Chinensis saponins and its monomers
[J]. Journal of Chinese Pharmaceutical Sciences, 2021, 30(5): 381-392.
|
| [4] |
Dakuan Wang, Bo Peng, Mengmeng Qin, Minghui Li, Ge Song, Bing He, Hua Zhang, Wenbing Dai, Qiang Zhang, Xiangbao Meng, Huan Meng, Xueqing Wang.
Integrated combination delivery of IDO inhibitor and paclitaxel for cancer treatment
[J]. Journal of Chinese Pharmaceutical Sciences, 2021, 30(1): 1-16.
|
| [5] |
Man Liu, Shuang Zhang, Zhuoyue Li, Guangxue Wang, Jingru Wang, Xuan Zhang.
Preparation and characterization of zinc oxide nanoparticles
[J]. Journal of Chinese Pharmaceutical Sciences, 2020, 29(9): 617-625.
|
| [6] |
Shen Lin, Xin Rao, Yiyuan Li, Xiuhua Weng, Changlian Wang.
Cost-effectiveness analysis of second-line chemotherapy strategies for patients with advanced non-squamous non-small cell lung cancer
[J]. Journal of Chinese Pharmaceutical Sciences, 2020, 29(8): 542-553.
|
| [7] |
Meng Lei, Xueyuan Wang, Hang Miao, Jia Wang, Sijia Sha, Jiang Zhu, Yongqiang Zhu.
Co-delivery of paclitaxel and gemcitabine via folic acid-conjugated polymeric multi-drug nanoparticles (FA-PMDNPs) for the treatment of breast cancer
[J]. Journal of Chinese Pharmaceutical Sciences, 2020, 29(10): 701-710.
|
| [8] |
Li Lei, Yu Chen, Simin Yang, Xiangbao Meng, Siwang Yu.
A novel aza-naphthoquinone inhibits tumor growth by inducing apoptosis
[J]. Journal of Chinese Pharmaceutical Sciences, 2018, 27(9): 600-607.
|
| [9] |
Gangzhi Zhu, Qin Yi, Zhihong Fan, Yuehui Ma, Dandan Wang, Lei Wang, Zeneng Cheng.
Determination of a novel derivative of the PAC-1 anticancer agent in rat plasma by LC-MS/MS and its application to a pharmacokinetics study
[J]. Journal of Chinese Pharmaceutical Sciences, 2017, 26(11): 811-818.
|
| [10] |
Jiabei Chen, Yufen Zheng, Weiqi Kong, Xin Li, Laichun Luo, Yanjun Han, Songwen Lin, Qi Sun, Zemei Ge, Runtao Li.
Design, synthesis and anti-tumor activities of cyclic phosphoramidate mustard-quinazoline conjugates
[J]. Journal of Chinese Pharmaceutical Sciences, 2017, 26(10): 727-736.
|
| [11] |
Yixin Chen, Xia Yuan, Zemei Ge, Fuxiang Ran, Jun Wu, Runtao Li, Jingrong Cui .
Effects of compound YSY-01A, a novel proteasome inhibitor, on MGC-803 cells and its related mechanism
[J]. Journal of Chinese Pharmaceutical Sciences, 2014, 23(9): 601-609.
|
| [12] |
Ke Yang, Xinghuo Li, Dan Li, Xiyu Ke, Xuan Zhang, Qiang Zhang.
The anti-tumor efficacy of c9, t11-CLA-PTX and t10, c12-CLA-PTX on MCF-7 breast cancer cells: in vitro and in vivo
[J]. Journal of Chinese Pharmaceutical Sciences, 2014, 23(11): 751-759.
|
| [13] |
Yingfeng Wang*, Yi Zheng, Baoshan Ku, Haiyan Yao, Guangyin Yao, Yangli Wan.
Anti-tumor activity of Hedyotis diffusa Willd. in mice
[J]. , 2013, 22(3): 272-276.
|
| [14] |
Yan Lu, Li-Na Liu, Hong-Gang Lou, Xiang Xu*.
Shenfu injection protects against myelosuppression from chemotherapy
[J]. , 2012, 21(4): 345-349.
|
| [15] |
Rui Sun, Jing Song, Hui Zhao, Chun-Li Yan, Ai-Jun Zhang, Diwa Koirala, Da-Wei Li, Chun Hu*.
Synthesis and anti-tumor activity of 1,4-dihydrothieno[3',2':5,6]thiopyrano[4,3-c]pyrazole-3-carboxylic amide derivatives
[J]. , 2011, 20(1): 32-36.
|
>
>